Exploring patient experience and satisfaction with depot buprenorphine formulations: A mixed‐methods study

Introduction The introduction of depot buprenorphine for the treatment of opioid dependence allows for reduced dosing frequency compared with conventional treatments, such as oral methadone and sublingual buprenorphine‐naloxone. Reduced dosing frequency is perceived to reduce issues such as high out...

Ausführliche Beschreibung